What is the current valuation of the US blood glucose test strip market?

The market valuation was 1.12 USD Billion in 2024. Read More

What is the projected market size for the US blood glucose test strip market by 2035?

The projected valuation for 2035 is 1.93 USD Billion. Read More

What is the expected CAGR for the US blood glucose test strip market during the forecast period 2025 - 2035?

The expected CAGR is 5.04% during the forecast period 2025 - 2035. Read More

Which companies are the key players in the US blood glucose test strip market?

Key players include Abbott Laboratories, Roche Diagnostics, Bayer HealthCare, LifeScan, Dexcom, Ascensia Diabetes Care, Arkray, and Nova Biomedical. Read More

How does the market segment by application perform in terms of valuation?

In 2024, the Self-Monitoring segment was valued at 0.56 USD Billion, while Continuous Glucose Monitoring reached 0.32 USD Billion. Read More

What are the projected valuations for the Home Care and Hospital segments by 2035?

The Home Care segment is projected to reach 0.95 USD Billion, and the Hospital segment is expected to reach 0.54 USD Billion by 2035. Read More

What distribution channels are most significant in the US blood glucose test strip market?

Pharmacy Chains had a valuation of 0.35 USD Billion in 2024, while Online Retail was valued at 0.25 USD Billion. Read More

What product types are included in the US blood glucose test strip market?

Product types include Blood Glucose Test Strips, Control Solutions, Lancing Devices, and Test Strip Accessories. Read More

What is the expected growth trend for the Clinical Testing segment?

The Clinical Testing segment was valued at 0.16 USD Billion in 2024 and is projected to grow to 0.30 USD Billion by 2035. Read More

How do the projected revenues for test strip accessories compare to other product types?

Test Strip Accessories were valued at 0.16 USD Billion in 2024 and are expected to reach 0.25 USD Billion by 2035. Read More

US Blood Glucose Test Strip Market

ID: MRFR/MED/15143-HCR

100 Pages

Garvit Vyas

Last Updated: April 06, 2026

United States Blood Glucose Test Strip Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

US Blood Glucose Test Strip Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Self-Monitoring
  2. 4.1.2 Continuous Glucose Monitoring
  3. 4.1.3 Clinical Testing
  4. 4.1.4 Research and Development
2. 4.2 Healthcare, BY End Use (USD Billion)
  1. 4.2.1 Home Care
  2. 4.2.2 Hospitals
  3. 4.2.3 Diagnostic Laboratories
  4. 4.2.4 Pharmacies
3. 4.3 Healthcare, BY Distribution Channel (USD Billion)
  1. 4.3.1 Online Retail
  2. 4.3.2 Pharmacy Chains
  3. 4.3.3 Supermarkets
  4. 4.3.4 Direct Sales
4. 4.4 Healthcare, BY Product Type (USD Billion)
  1. 4.4.1 Blood Glucose Test Strips
  2. 4.4.2 Control Solutions
  3. 4.4.3 Lancing Devices
  4. 4.4.4 Test Strip Accessories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer HealthCare (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 LifeScan (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Dexcom (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Ascensia Diabetes Care (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Arkray (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Nova Biomedical (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY END USE
4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 US MARKET ANALYSIS BY PRODUCT TYPE
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 HEALTHCARE, BY END USE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
16. 6.16 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
18. 6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
  4. 7.2.4 BY PRODUCT TYPE, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2022-2035)

Self-Monitoring
Continuous Glucose Monitoring
Clinical Testing
Research and Development

Healthcare By End Use (USD Billion, 2022-2035)

Home Care
Hospitals
Diagnostic Laboratories
Pharmacies

Healthcare By Distribution Channel (USD Billion, 2022-2035)

Online Retail
Pharmacy Chains
Supermarkets
Direct Sales

Healthcare By Product Type (USD Billion, 2022-2035)

Blood Glucose Test Strips
Control Solutions
Lancing Devices
Test Strip Accessories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”